Latest Psychedelic News

UC Berkeley launches new center for psychedelic science and education

Psychedelic Reform

With anonymous seed funding of $1.25 million, UC Berkeley will begin to conduct research using psychedelics to investigate cognition, perception, and emotion.

September 16, 2020
Yasmin Anwar

Could Group Therapy Make Psychedelic Drug Treatments More Accessible?

Psychedelic Reform

Older adults are now moving toward using psychedelics and cannabis as a way to treat illnesses at an affordable cost.

September 16, 2020
Abbie Rosner

How Psychedelics Helped Riley Cote

Spotlight Original

Heavy Hits: How Psychedelics Helped an Ex-NHL Enforcer Drop the Gloves and Beat His PTSD Straight into the Sin Bin

September 15, 2020
David Flores

Compass Pathways Set to Become the First Psychedelic Biotech IPO

Investor News

Compass Pathways isn’t the first company to fashion FDA-regulated therapies out of psilocybin, but it intends to be the first one to go public.

September 15, 2020
Damian Garde

CEO of Canadian Stock Exchange on Psychedelic Investments

Investor News

Science and data suggest psychedelics aren’t cannabis

September 14, 2020
Nick Mistretta

Ketamine: The Greatest Drug in the World?

Science & Research

Use the wrong term or phrase to describe a peculiar experience associated with an experimental drug, and it’s sure to be the old nail in the molecule’s coffin.

September 11, 2020
Jennifer Walker-Journey

Canadian Manufacturer Licensed To Make Psilocybin

Lifestyle Features

Mydecine Innovations Group is first to legally produce and distribute pharmaceutical-grade psilocybin.

September 10, 2020
Jill Ettinger

Could Low Doses of LSD Make Opiods Obsolete?

Science & Research

Better known for its psychedelic properties, Lysergic Acid Diethylamide (LSD) became extremely popular during the counterculture of the 1960’s.

September 9, 2020
Bianca Blanche